| |
Values at baseline (SD)
|
Difference between aVQ and control
|
|---|
| |
aVQ
|
Control
|
t
|
t
|
t
|
t
|
F
|
|---|
| | | |
at baseline
|
at week 8
|
at week 16
|
at week 24
|
ANOVA
|
|---|
|
WBCx1000/μl
|
6.21 (2.13)
|
5.24 (1.17)
|
−1.595
|
−2.1951*
|
−2.0243
|
−2.1076*
|
7.614*
|
|
Platelets x1000/μl
|
61.38 (77.07)
|
72.19 (83.77)
|
0.38
|
−0.5491
|
0.2193
|
0.3207
|
0.0442
|
|
Neutrophils %
|
64.65 (8)
|
63.66 (8.29)
|
−0.345
|
−0.7475
|
1.6094
|
−0.291
|
0.0055
|
|
Lymphocytes %
|
21.83 (6.37)
|
22.94 (7.51)
|
0.4493
|
2.1109*
|
−0.068
|
1.0294
|
1.5019
|
|
Monocytes %
|
7.07 (2.91)
|
7.74 (3.69)
|
0.5746
|
0.5052
|
0.2823
|
0.8871
|
0.776
|
|
Eosinophils %
|
6.08 (3.89)
|
4.91 (2.39)
|
−1.028
|
−3.677**
|
−3.2466**
|
−2.3029*
|
10.1286**
|
|
Basophiles %
|
0.37 (0.21)
|
0.76 (0.63)
|
2.3308*
|
0.4129
|
0.0282
|
−0.081
|
2.0996
|
|
Protein g/dl
|
6.16 (0.44)
|
6.31 (0.37)
|
1.0894
|
0.1437
|
0.3964
|
1.0308
|
0.4806
|
|
AST U/l+
|
19.62 (4.26)
|
21 (8.48)
|
0.5798
|
0.4339
|
1.0689
|
0.4566
|
0.6618
|
|
ALT U/l†
|
19.44 (9.39)
|
20.31 (11.27)
|
0.2386
|
0.064
|
1.3147
|
−0.0086
|
0.2651
|
|
ALK U/l‡
|
65.75 (16.43)
|
72.56 (48.02)
|
0.5369
|
−2.146*
|
−3.0221**
|
−2.8479**
|
2.6545
|
|
Bilirubin mg/dl
|
0.84 (0.24)
|
0.79 (0.28)
|
−0.471
|
−0.1546
|
−0.4448
|
−0.6975
|
0.2735
|
- +AST: aspartate aminotransferase; †ALT: alanine aminotransferase; ‡ ALK: alkaline phosphatase; *p<0.05 **p<0.01.
